US Patent Issued to QURE BIOTECHNOLOGY (SHANGHAI) on July 28 for "Anti-CLDN antibody and pharmaceutical composition thereof and detection method therefor" (Chinese Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,309, issued on July 28, was assigned to QURE BIOTECHNOLOGY (SHANGHAI) Co. LTD. (Shanghai).

"Anti-CLDN antibody and pharmaceutical composition thereof and detection method therefor" was invented by Xiangdong Qu (Shanghai), Qin Pan (Shanghai), Houcong Jin (Shanghai), Yejie Du (Shanghai) and Han Zheng (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are an anti-CLDN18.2 antibody and a pharmaceutical composition thereof and a detection method therefor, wherein the heavy chain of the antibody is selected from any one of SEQ ID NOs: 1-7 or SEQ ID NOs: 15-30, and the light chain of the antibody is selected from any one of SEQ ID NOs: 8-14 ...